Anti-seizure medication tapering correlates with daytime delta band power reduction in the cortex
Anti-seizure medications (ASMs) are the primary treatment for epilepsy, yet medication tapering effects have not been investigated in a dose, region, and time-dependent manner, despite their potential impact on research and clinical practice. We examined over 3000 hours of intracranial EEG recordings in 32 subjects during long-term monitoring, of which 22 underwent concurrent ASM tapering. We estimated ASM plasma levels based on known pharmaco-kinetics of all the major ASM types. We found an overall decrease in the power of delta band activity around the period of maximum medication withdrawal in most (80%) subjects, independent of their epilepsy type or medication combination. The degree of withdrawal correlated positively with the magnitude of delta power decrease. This dose-dependent effect was evident across all recorded cortical regions during daytime; but not in sub-cortical regions, or during night time. We found no evidence of a differential effect in seizure onset, spiking, or pathological brain regions. The finding of decreased delta band power during ASM tapering agrees with previous literature. Our observed dose-dependent effect indicates that monitoring ASM levels in cortical regions may be feasible for applications such as medication reminder systems, or closed-loop ASM delivery systems. ASMs are also used in other neurological and psychiatric conditions, making our findings relevant to a general neuroscience and neurology audience.
Code (1)
Tasks
EEGSimilar Papers 제목 키워드 기반
Dual mechanism of Anti-Seizure Medications in controlling seizure activity
Background: Anti-seizure medications (ASMs) can reduce seizure duration, but their precise modes of action are unclear. Specifically, it is unknown whether ASMs shorten seizures by simply compressing existing seizure act…
EEGAnti-seizure medication load is not correlated with early termination of seizure spread
Objective: Anti-seizure medications (ASMs) are the mainstay of treatment for epilepsy, yet their effect on seizure spread is not fully understood. Higher ASM doses have been associated with shorter and less severe seizur…
EEGFrom Epilepsy Seizures Classification to Detection: A Deep Learning-based Approach for Raw EEG Signals
Epilepsy represents the most prevalent neurological disease in the world. One-third of people suffering from mesial temporal lobe epilepsy (MTLE) exhibit drug resistance, urging the need to develop new treatments. A key …
EEGElectroencephalogram (EEG)Seizure DetectionMulti-Channel Vision Transformer for Epileptic Seizure Prediction
Epilepsy is a neurological disorder that causes recurrent seizures and sometimes loss of awareness. Around 30% of epileptic patients continue to have seizures despite taking anti-seizure medication. The ability to predic…
EEGPredictionSeizure predictionTime SeriesSeizures and epilepsy after intracerebral hemorrhage: an update
Seizures are common after intracerebral hemorrhage, occurring in 6 to 15% of the patients, mostly in the first 72 hours. Their incidence reaches 30% when subclinical or non-convulsive seizures are diagnosed by continuous…
Prognosis